Updated findings for belzutifan showed that with further follow-up, the hypoxia-inducible factor-2 alpha inhibitor continues to show significant clinical activity in patients with Von-Hippel Lindau–associated renal cell carcinoma treated in the frontline setting. Updated results from the phase 2 study. Women’s use of facial skin care products saw a significant rise in 2020 due to the COVID-19 pandemic, according to The NPD Group, a market research company. itthikorn / stock.adobe.com Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. Exum Instruments, Inc. introduced Massbox, the first commercial instrument combining laser ablation and laser ionization under vacuum. Lightigo exhibited FireFly, an instrument specializing on chemical imaging of solid samples and featuring a motorized objective turret, laser microfocus, and long depth of field. Lightigo’s FireFly could have also been placed in the “Imaging” category. It’s no secret that veterinary professionals are resilient. During the COVID-19 pandemic, the profession was confronted with significant challenges but adjusted to sudden, drastic changes and propelled forward to meet the new and growing demands. “Our profession is resilient, and if our profession is resilient, that means the professionals within the profession are resilient,” said Kara Burns, MS, MEd, LVT, VTS (Nutrition). “If we’re resilient it means we [have] recovered from [things] and learned to change course and move forward.” When faced with adversity because of a worldwide pandemic or a challenging situation in the clinic—having the right tools to help you maintain resiliency is crucial. During her talk during the 2021 vi Updated findings for belzutifan (MK-6482) showed that with further follow-up, the hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor continues to show significant clinical activity in patients with Von-Hippel Lindau (VHL)–associated renal cell carcinoma (RCC) treated in the frontline setting. U A recent review explored gender differences in chronic cough and considered several possible explanations for these differences. Understanding why this difference exists could assist with finding new therapies, said the authors, writing in Frontiers of Physiology. Chronic cough, which lasts longer than 8 weeks, affects quality of life and is one of the main reasons people seek medical treatment, the authors noted. Reasons for chronic cough in nonsmokers include asthma, bronchitis, postnasal drip, and cough related to gastroesophageal reflux disease (GERD). Worldwide, about 2/3 of all patients with chronic cough are female, although in China it varies by region and prevalence may be about the same between both sexes. This apparent lack of a gender difference in China may be due to the types of patients enrolled in studies or to certain aspects of their health care sy